These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10309085)

  • 1. A comparison of premixed and non-premixed potassium chloride large-volume parenterals.
    Turco SJ
    Hosp Pharm; 1979 Dec; 14(12):720-2. PubMed ID: 10309085
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost and time required to add potassium chloride to large-volume parenterals.
    Turco SJ
    Hosp Pharm; 1979 Dec; 14(12):718-9. PubMed ID: 10309084
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the pump syringe method with other methods for adding potassium chloride to Travenol large-volume parenterals.
    Moeller KA; Clyne KE
    Hosp Pharm; 1980 Dec; 15(12):605-7. PubMed ID: 10249421
    [No Abstract]   [Full Text] [Related]  

  • 4. Analyzing captial investments.
    Gray SP
    Hosp Purch Manage; 1980 Sep; 5(9):3-7. PubMed ID: 10309238
    [No Abstract]   [Full Text] [Related]  

  • 5. Purchasing premixed products.
    Geberbauer CW
    J Healthc Mater Manage; 1988; 6(2):40, 42, 44-5. PubMed ID: 10286278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of gentamicin premixed admixtures: cost and clinical utility.
    Zarowitz BJ; Owen H; Popovich J; Pancorbo S
    Hosp Pharm; 1987 Mar; 22(3):257-60. PubMed ID: 10311980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automatic pipetters: applications and cost considerations in I.V. admixture programs.
    Blackstone M; Hauser LD
    Hosp Mater Manage Q; 1980 Feb; 1(3):69-85. PubMed ID: 10309094
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost, motion, and time studies comparing a new cephalosporin admixture system.
    Turco SJ
    Hosp Pharm; 1982 Dec; 17(12):653-8. PubMed ID: 10257925
    [No Abstract]   [Full Text] [Related]  

  • 9. Personnel costs and preparation time in a centralized intravenous admixture program.
    Ryan DM; Daniels CE; Somani SM
    Am J Hosp Pharm; 1986 May; 43(5):1222-5. PubMed ID: 3087164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personnel time and preparation costs for compounded versus premixed intravenous admixtures in three community hospitals.
    Kirschenbaum BE; Cacace L; Anderson RJ; Ackerman LA
    Am J Hosp Pharm; 1988 Mar; 45(3):605-8. PubMed ID: 3369464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premixed intravenous admixtures: a critical challenge for hospital pharmacy.
    Loeb AJ; Fishman DA; Kochis TR
    Am J Hosp Pharm; 1983 Jun; 40(6):1041-3. PubMed ID: 6869392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premixed intravenous admixtures: a positive development for hospital pharmacy.
    Lee HE
    Am J Hosp Pharm; 1983 Jun; 40(6):1043-4. PubMed ID: 6869393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of wastage in a hospital intravenous admixture program.
    Salberg DJ; Newton RW; Leduc DT
    Hosp Formul; 1984 May; 19(5):375-8. PubMed ID: 10266241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The high cost of customization: compounding drugs.
    Cohen MR
    Hosp Pharm; 1991 Apr; 26(4):384-5. PubMed ID: 10113578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an IV admixture program in a 167-bed hospital.
    Wyatt BK
    Hosp Pharm; 1975 Jun; 10(6):225-9. PubMed ID: 10237880
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost analysis of using premixed frozen versus hospital-reconstituted cefazolin sodium injection.
    Havlovic DA; Ivey MF; Grotzinger RP
    Am J Hosp Pharm; 1987 Apr; 44(4):783-7. PubMed ID: 3578311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commercial premixed parenteral nutrition: Is it right for your institution?
    Miller SJ
    Nutr Clin Pract; 2009; 24(4):459-69. PubMed ID: 19605800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations to pharmacists for solving problems with large-volume parenterals.
    Am J Hosp Pharm; 1976 Mar; 33(3):231-6. PubMed ID: 816199
    [No Abstract]   [Full Text] [Related]  

  • 20. Recommended methods for compounding intravenous admixtures in hospitals.
    Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.